Form 4: Cryoport Director Ramkumar Mandalam Reports Stock Grant and Option Award

Director Ramkumar Mandalam reports receiving a grant of restricted stock rights and an option award for Cryoport, Inc.

Summary

• On May 17, 2024, Ramkumar Mandalam, a director of Cryoport, Inc., reported a transaction involving the company's securities.
• Mandalam acquired 12,845 shares of common stock through a grant of restricted stock rights at a price of $0.
• These restricted stock rights vest in full on May 17, 2025, and automatically convert to common stock on a one-for-one basis.
• Mandalam also acquired an option to buy 23,830 shares of common stock at an exercise price of $12.65.
• 1/12th of the options vest on the 17th of the month for twelve months beginning June 17, 2024, expiring on May 17, 2031.
• Following these transactions, Mandalam beneficially owns 56,032 shares of common stock and 23,830 options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of equity to a director is a standard practice and suggests confidence in the company's future performance. The vesting schedule further aligns the director's interests with long-term shareholder value.

Positives

• The grant of restricted stock rights and options to a director aligns their interests with those of the shareholders.
• The vesting schedule of the options incentivizes continued service and contribution to the company's success.

Industry Context

This type of equity compensation is common in the biotech and pharmaceutical industries to attract and retain talent, aligning management's interests with long-term shareholder value.

Comparison to Industry Standards

• Equity grants to directors are a standard practice across publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• Companies such as BioLife Solutions and Thermo Fisher Scientific also utilize stock options and restricted stock units as part of their compensation packages for directors and executives.
• The vesting schedules and exercise prices are generally structured to incentivize long-term performance and alignment with shareholder interests, similar to the terms observed in this filing.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align the director's interests with the company's long-term success.
• Employees may see this as a sign of the company's commitment to its leadership team.

Key Dates